Stifel Nicolaus Has Lowered Expectations for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL - Get Free Report) had its target price decreased by equities research analysts at Stifel Nicolaus from $101.00 to $95.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a "hold" rating on the stock. Stifel Nicolaus' target price indicates a potential upside of 6.99% from the stock's current price.

Other research analysts have also recently issued research reports about the company. UBS Group dropped their price target on Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating for the company in a research report on Thursday. Barclays dropped their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday. JPMorgan Chase & Co. dropped their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a research report on Thursday. Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Finally, TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and a consensus price target of $101.11.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded up $0.23 during midday trading on Friday, reaching $88.79. The company's stock had a trading volume of 5,149,874 shares, compared to its average volume of 3,679,883. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock's 50 day simple moving average is $92.20 and its 200 day simple moving average is $97.74. The firm has a market capitalization of $72.55 billion, a PE ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Colgate-Palmolive

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $64,000. True Wealth Design LLC increased its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after acquiring an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC grew its stake in Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after buying an additional 368 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.